GlassScriptPhysician profile
Ankaj Khosla
NPI 1033485859
$1,261.96
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.40 · 2020: $230 · 2021: $832 · 2022: $168.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $476.47 | 2020-2021 | |
| Stryker Corporation | $377.02 | 2021-2022 | |
| Abbott Laboratories | $145.97 | 2021 | |
| Medtronic, INC. | $70.00 | 2022 | |
| Medtronic Vascular, INC. | $32.40 | 2019 | |
| Cardiva Medical, INC. | $32.22 | 2021 | |
| Inari Medical, INC. | $29.49 | 2022 | |
| Siemens Medical Solutions USA, INC. | $28.91 | 2022 | |
| Boston Scientific Corporation | $20.83 | 2020 | |
| Shockwave Medical, INC | $20.50 | 2020 | |
| Philips North America LLC | $14.87 | 2020 | |
| Cardiovascular Systems INC. | $13.28 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankaj Khosla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.